Lindbrook Capital, LLC Takeda Pharmaceutical CO LTD Transaction History

Lindbrook Capital, LLC

$1.06 Billion
Q1 2025

A detailed history of Lindbrook Capital, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Lindbrook Capital, LLC holds 4,292 shares of TAK stock, worth $61,332. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,292

Previous 5,151 16.68%

Holding current value

$61,332

Previous $68,000 7.35%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$12.89 - $15.19 $11,072 - $13,048	-859 Reduced 16.68%	4,292 $63,000
Q4 2024 Feb 06, 2025	BUY	$13.01 - $14.43 $26,397 - $29,278	2,029 Added 64.99%	5,151 $68,000
Q3 2024 Nov 01, 2024	BUY	$13.0 - $15.08 $6,851 - $7,947	527 Added 20.31%	3,122 $44,000
Q2 2024 Jul 31, 2024	SELL	$12.6 - $13.67 $22,680 - $24,606	-1,800 Reduced 40.96%	2,595 $33,000
Q1 2024 Apr 25, 2024	BUY	$13.89 - $15.04 $4,583 - $4,963	330 Added 8.12%	4,395 $61,000

Q4 2023 Jan 31, 2024	BUY	$13.36 - $15.43 $15,684 - $18,114	1,174 Added 40.61%	4,065 $58,000
Q3 2023 Oct 25, 2023	SELL	$15.03 - $16.32 $42,865 - $46,544	-2,852 Reduced 49.66%	2,891 $44,000
Q2 2023 Jul 28, 2023	SELL	$15.57 - $17.11 $27,045 - $29,720	-1,737 Reduced 23.22%	5,743 $90,000
Q1 2023 Apr 26, 2023	BUY	$15.28 - $16.48 $44,846 - $48,368	2,935 Added 64.58%	7,480 $123,000
Q4 2022 Jan 24, 2023	SELL	$12.42 - $15.62 $26,168 - $32,911	-2,107 Reduced 31.67%	4,545 $0
Q3 2022 Nov 10, 2022	BUY	$12.8 - $28.65 $8,038 - $17,992	628 Added 10.42%	6,652 $86,000
Q2 2022 Aug 01, 2022	SELL	$13.12 - $15.03 $15,993 - $18,321	-1,219 Reduced 16.83%	6,024 $85,000
Q1 2022 Apr 21, 2022	BUY	$13.54 - $15.35 $26,782 - $30,362	1,978 Added 37.57%	7,243 $104,000
Q4 2021 Jan 18, 2022	SELL	$13.17 - $16.4 $5,017 - $6,248	-381 Reduced 6.75%	5,265 $72,000
Q3 2021 Nov 05, 2021	BUY	$16.3 - $17.26 $4,987 - $5,281	306 Added 5.73%	5,646 $92,000
Q2 2021 Jul 27, 2021	SELL	$16.55 - $18.64 $27,737 - $31,240	-1,676 Reduced 23.89%	5,340 $90,000
Q1 2021 Apr 28, 2021	BUY	$16.71 - $19.9 $9,792 - $11,661	586 Added 9.11%	7,016 $128,000
Q4 2020 Jan 27, 2021	BUY	$15.39 - $18.97 $8,956 - $11,040	582 Added 9.95%	6,430 $117,000
Q3 2020 Nov 03, 2020	BUY	$17.1 - $19.19 $4,275 - $4,797	250 Added 4.47%	5,848 $104,000
Q2 2020 Jul 27, 2020	BUY	$14.59 - $19.5 $19,448 - $25,993	1,333 Added 31.25%	5,598 $100,000
Q1 2020 Apr 22, 2020	SELL	$13.02 - $20.31 $9,960 - $15,537	-765 Reduced 15.21%	4,265 $65,000
Q4 2019 Jan 27, 2020	SELL	$16.88 - $20.83 $13,115 - $16,184	-777 Reduced 13.38%	5,030 $99,000
Q3 2019 Oct 31, 2019	BUY	$16.15 - $17.99 $38,372 - $42,744	2,376 Added 69.25%	5,807 $100,000
Q2 2019 Jul 24, 2019	SELL	$16.58 - $20.49 $69,636 - $86,058	-4,200 Reduced 55.04%	3,431 $60,000
Q1 2019 Apr 23, 2019	BUY	$16.7 - $21.52 $127,437 - $164,219	7,631 New	7,631 $155,000

Others Institutions Holding TAK

# of Institutions

381

Shares Held

80.7M

Call Options Held

1.67M

Put Options Held

276K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Takeda Pharmaceutical CO LTD Transaction History